On July 22, 2025, Replimune publicly announced that the U.S. Food and Drug Administration (FDA) had issued a "Complete Response Letter" (CRL) for its Biologics License Application (BLA) for RP1. This ...

Replimune's RP1, an oncolytic immuno-gene therapy, shows promise with a 31.4% ORR in phase 2 trials for post PD-1 melanoma and non-melanoma skin cancers. RP2, adding an anti-CTLA-4 component to RP1, ...

The biggest stories of the day delivered to your inbox.

Send a note to Doug Wintemute, Kara Coleman Fields and our other editors. We read every email. By submitting this form, you agree to allow us to collect, store, and potentially publish your provided ...

With three years spent researching, comparing, and testing software products, Tyler Webb is an expert on all things telecommunications. With work featured on GetVoIP.com, he's written over 150 ...

Auditory processing disorder (APD) is a hearing condition in which your brain has a problem processing sounds. This can affect how you understand speech and other sounds in your environment. For ...

Nasdaq provides updated worldwide news headlines. Here you can find up-to-the-minute news and analysis of the company that you are researching for potential investment opportunities.

Call and put options are quoted in a table called a chain sheet. The chain sheet shows the price, volume and open interest for each option strike price and expiration month. Nasdaq provides call and ...

In the past, most small-business owners got by with a typewriter, handwritten notes and a basic text-editor program, but modern-day business professionals depend on a word processor. Whether you're ...